Published in Eur Heart J on September 01, 1998
Population need for coronary revascularisation: are national targets for England credible? Heart (2002) 1.03
Age difference explains gender difference in cardiac intervention rates after acute myocardial infarction. Healthc Policy (2010) 0.83
Routine coronary angiographic follow-up and subsequent revascularization in patients with acute myocardial infarction. Heart Vessels (2008) 0.81
Sex differences in coronary catheterization and revascularization following acute myocardial infarction: time trends from 1994 to 2003 in British Columbia. Can J Cardiol (2010) 0.80
Coronary angiography and revascularization following acute myocardial infarction. Eur Heart J (1998) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med (1984) 4.51
A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell (1997) 4.43
Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet (1974) 4.40
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Smoking and myocardial infarction. Lancet (1975) 3.42
A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature (1997) 3.26
Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci U S A (1989) 3.24
Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15
Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J (1997) 3.11
Multivariate analysis of risk factors for coronary heart disease. Circulation (1973) 3.04
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation (1990) 2.89
Rearrangement of genetic information may produce immunoglobulin diversity. Nature (1979) 2.84
Amino acid sequence of a mouse immunoglobulin mu chain. Proc Natl Acad Sci U S A (1979) 2.74
Bias due to non-participation and heterogenous sub-groups in population surveys. J Chronic Dis (1983) 2.62
Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57
Drosophila neuroglian: a member of the immunoglobulin superfamily with extensive homology to the vertebrate neural adhesion molecule L1. Cell (1989) 2.44
Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. Proc Natl Acad Sci U S A (1987) 2.43
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med (1999) 2.35
Daughter of sevenless is a substrate of the phosphotyrosine phosphatase Corkscrew and functions during sevenless signaling. Cell (1996) 2.30
The joining of V and J gene segments creates antibody diversity. Nature (1980) 2.28
Isolation and characterization of the human pulmonary surfactant apoprotein gene. Nature (1985) 2.27
Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet (1985) 2.26
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis (1975) 2.20
Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J (1999) 2.16
Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J (1989) 2.14
Parent-child agreement on child psychiatric symptoms assessed via structured interview. J Child Psychol Psychiatry (1986) 2.11
Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet (1998) 2.06
Thrombolytic therapy for acute myocardial infarction in older patients. Lancet (1996) 2.03
Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol (1975) 1.94
Amino acid sequence of homogeneous antibodies to dextran and DNA rearrangements in heavy chain V-region gene segments. Nature (1980) 1.94
Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax (2005) 1.92
A primary preventive study of Gothenburg, Sweden. Prev Med (1972) 1.92
The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell (1995) 1.91
Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun (1989) 1.91
Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90
Influencing sceptical staff to become supporters of service improvement: a qualitative study of doctors' and managers' views. Qual Saf Health Care (2004) 1.87
The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85
Polymer nanotubes by wetting of ordered porous templates. Science (2002) 1.84
A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis (1976) 1.80
Isolation and characterization of light-regulated phycobilisome linker polypeptide genes and their transcription as a polycistronic mRNA. J Bacteriol (1987) 1.78
Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med (1999) 1.76
Prevalence and management of hypertension in a general population sample of Swedish men. Prev Med (1973) 1.76
Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Göteborg. Ann Epidemiol (1997) 1.75
Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost (2007) 1.74
Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. Eur Heart J (1998) 1.73
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol (1992) 1.66
Stressful life events, social support, and mortality in men born in 1933. BMJ (1993) 1.66
Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax (2009) 1.65
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. Am J Cardiol (1991) 1.63
Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med (1992) 1.62
CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J (2009) 1.62
Structure and expression of the gene encoding the periplasmic arylsulfatase of Chlamydomonas reinhardtii. Mol Gen Genet (1989) 1.62
Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ (1989) 1.61
Irreversible myocardial injury in anoxic perfused rat hearts. Am J Pathol (1975) 1.60
Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke (1990) 1.59
Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med (1993) 1.57
Cholesterol and total mortality: need for larger trials. BMJ (1992) 1.57
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia (1988) 1.53
Coronary heart disease and mortality in middle aged men from different occupational classes in Sweden. BMJ (1988) 1.53
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ (1990) 1.50
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies. Eur Heart J (2001) 1.49
Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J (1989) 1.47
Structural correlates of cross-reactive and individual idiotypic determinants on murine antibodies to alpha-(1 leads to 3) dextran. J Exp Med (1980) 1.46
Organization and efficacy of an out-patient hypertension clinic. Acta Med Scand (1978) 1.45
Structure of canine pulmonary surfactant apoprotein: cDNA and complete amino acid sequence. Proc Natl Acad Sci U S A (1985) 1.45
Carvedilol for prevention of restenosis after directional coronary atherectomy : final results of the European carvedilol atherectomy restenosis (EUROCARE) trial. Circulation (2000) 1.43
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
Improved long-term prognosis after myocardial infarction 1984-1991. Eur Heart J (1998) 1.42
Fatalities from myocardial infarction in Nordic countries and Lithuania. The MONICA Investigators. Eur Heart J (1997) 1.42
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1998) 1.42
Ambulatory electrocardiographic recording in endurance athletes. Br Heart J (1982) 1.42
Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Nephrol Dial Transplant (1998) 1.39
The structure and genetics of mouse immunoglobulins: an analysis of NZB myeloma proteins and sets of BALB/c myeloma proteins binding particular haptens. Cold Spring Harb Symp Quant Biol (1977) 1.38